Eli Lilly and Innovent Biologics partner on the distribution and promotion of Jaypirca in China, the first non-covalent BTK ...

RemeGen’s Phase III trial of disitamab vedotin shows improved progression-free survival in advanced breast cancer patients ...

Japan’s largest drugmaker, Takeda Pharmaceuticals, announced it is working with the European Medicines Agency (EMA) to ...

Dewpoint Therapeutics and ConcertAI have announced the first phase of their translational oncology partnership, aligned ...

Switzerland’s Galderma has won US Food and Drug Administration (FDA) approval for the use of Nemluvio (nemolizumab) for ...

The schizophrenia market across the seven major markets is poised to grow at a compound annual growth rate (CAGR) of 7.4% ...

Denmark-based diabetes and obesity giant Novo Nordisk says it plans to invest 8.5 billion Danish kroner ($1.2 billion) to ...

Swedish biotech company Inify Laboratories has raised approximately 135 million kroner ($12.3 million) through a private ...

Shares of Swedish pharma firm Orexo leapt 20.2% to 20.60 kronor this morning, following its announcement over the weekend ...

UK-based Puretech Health has announced positive results from ELEVATE IPF, a Phase IIb trial of deupirfenidone (LYT-100) at ...

BioNTech resumes its PRESERVE-003 trial for gotistobart as a monotherapy in metastatic squamous NSCLC after a partial ...

VectorY Therapeutics appoints Jim Scibetta as CEO to lead development of VTx-002, a vectorized antibody therapy targeting TDP ...